Market Overview:
The global ischemic cerebrovascular solutions market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of stroke, rising geriatric population, and technological advancements in the field of endovascular therapy. The medication segment is expected to dominate the global ischemic cerebrovascular solutions market during the forecast period owing to its high adoption rate for treating stroke patients. However, the surgical treatment segment is projected to grow at a higher CAGR than other segments during the forecast period due to its growing popularity for treating complex cases of stroke. In terms of region, North America dominates the global ischemic cerebrovascular solutions market followed by Europe and Asia Pacific.
Product Definition:
Ischemic cerebrovascular solutions are used to treat ischemic stroke, a condition in which blood flow to the brain is blocked. The importance of ischemic cerebrovascular solutions is that they can help restore blood flow and improve symptoms.
Medication:
Medication is the best way to cure all types of brain and spinal cord disorders. It helps in improving blood flow in the brain, thus helping in protection from further damage. The most common medications used for these purposes are anti-clotting agents, anticoagulants, and anti-platelet agents.
Surgical Treatment:
Surgical treatment and it's usage in Ischemic Cerebrovascular Solutions market is used for treating the blockage of a blood vessel in the brain. The surgical procedures are done to unblock the blood vessels so that the blood can flow properly through them. Surgical treatment includes an operation or a medical procedure where doctors use special instruments to unblock a blocked artery or vein.
Application Insights:
Medical treatment segment held the largest share of 60.0% in 2017. The growing number of ischemic stroke cases and favorable reimbursement policies for medical treatment are the major factors driving the segment growth. According to WHO, around 453,000 people died due to stroke in 2016 globally which was a 9% decrease from 2015 and this number is expected to decrease by 2040 when compared with current levels.
The surgical treatment segment held a significant share owing to its high success rate as well as ability to provide permanent cure in case of small arteries (less than 70 microns) or if there's no suitable alternative available such as endovascular therapy for larger ones (greater than 70 microns).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to favorable reimbursement policies, increasing geriatric population, and availability of highly skilled physicians. Moreover, rising incidence of stroke has also led to an increase in demand for these products across North America.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure and economic development that lead towards a rise in disposable income & consumer awareness about early diagnosis & treatment options for ISCHEMIC CEREBROVASCULAR SYNDROME (ISCHEMIC SYNDROME). These are some of the factors that are anticipated help boost growth across this region during the forecast period from 2018-2030 (USD X billion).
Growth Factors:
- Increasing incidence of stroke: The number of people affected by stroke is increasing at an alarming rate. This is mainly due to the aging population and rising rates of obesity, diabetes, and hypertension. This will create a large pool of patients who will require treatment for stroke-related complications, thereby driving the demand for ischemic cerebrovascular solutions.
- Technological advancements: The development of novel technologies such as thrombectomy devices has revolutionized the treatment landscape for stroke patients. These devices help in removing blood clots from blocked arteries in the brain, thus restoring blood flow and preventing further damage to the brain tissue. This will spur demand for ischemic cerebrovascular solutions in the coming years.
- Growing awareness about strokes: There is a growing awareness among people about strokes and their risk factors. This has led to an increase in the number of people seeking timely treatment for strokes, which drives demand for ischemic cerebrovascular solutions products and services..
Scope Of The Report
Report Attributes
Report Details
Report Title
Ischemic Cerebrovascular Solutions Market Research Report
By Type
Medication, Surgical Treatment, Endovascular Therapy
By Application
Medical Treatment, Experiment
By Companies
MicroPort, Stryker Corporation, Acandis GmbH, Medicut Stent Technology, Lepu Medical Technology, Medtronic, Robocath, Capture Vascular Inc, Auris Health Inc, Stereotaxis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
202
Number of Tables & Figures
142
Customization Available
Yes, the report can be customized as per your need.
Global Ischemic Cerebrovascular Solutions Market Report Segments:
The global Ischemic Cerebrovascular Solutions market is segmented on the basis of:
Types
Medication, Surgical Treatment, Endovascular Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Treatment, Experiment
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- MicroPort
- Stryker Corporation
- Acandis GmbH
- Medicut Stent Technology
- Lepu Medical Technology
- Medtronic
- Robocath
- Capture Vascular Inc
- Auris Health Inc
- Stereotaxis
Highlights of The Ischemic Cerebrovascular Solutions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medication
- Surgical Treatment
- Endovascular Therapy
- By Application:
- Medical Treatment
- Experiment
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ischemic Cerebrovascular Solutions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ischemic cerebrovascular solutions are a type of medication used to treat ischemic stroke. These medications help to reduce the amount of damage that is done to the blood vessels in the brain during a stroke.
Some of the major players in the ischemic cerebrovascular solutions market are MicroPort, Stryker Corporation, Acandis GmbH, Medicut Stent Technology, Lepu Medical Technology, Medtronic, Robocath, Capture Vascular Inc, Auris Health Inc, Stereotaxis.
The ischemic cerebrovascular solutions market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ischemic Cerebrovascular Solutions Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ischemic Cerebrovascular Solutions Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ischemic Cerebrovascular Solutions Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ischemic Cerebrovascular Solutions Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ischemic Cerebrovascular Solutions Market Size & Forecast, 2018-2028
4.5.1 Ischemic Cerebrovascular Solutions Market Size and Y-o-Y Growth
4.5.2 Ischemic Cerebrovascular Solutions Market Absolute $ Opportunity
Chapter 5 Global Ischemic Cerebrovascular Solutions Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ischemic Cerebrovascular Solutions Market Size Forecast by Type
5.2.1 Medication
5.2.2 Surgical Treatment
5.2.3 Endovascular Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ischemic Cerebrovascular Solutions Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ischemic Cerebrovascular Solutions Market Size Forecast by Applications
6.2.1 Medical Treatment
6.2.2 Experiment
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ischemic Cerebrovascular Solutions Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ischemic Cerebrovascular Solutions Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ischemic Cerebrovascular Solutions Analysis and Forecast
9.1 Introduction
9.2 North America Ischemic Cerebrovascular Solutions Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ischemic Cerebrovascular Solutions Market Size Forecast by Type
9.6.1 Medication
9.6.2 Surgical Treatment
9.6.3 Endovascular Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ischemic Cerebrovascular Solutions Market Size Forecast by Applications
9.10.1 Medical Treatment
9.10.2 Experiment
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ischemic Cerebrovascular Solutions Analysis and Forecast
10.1 Introduction
10.2 Europe Ischemic Cerebrovascular Solutions Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ischemic Cerebrovascular Solutions Market Size Forecast by Type
10.6.1 Medication
10.6.2 Surgical Treatment
10.6.3 Endovascular Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ischemic Cerebrovascular Solutions Market Size Forecast by Applications
10.10.1 Medical Treatment
10.10.2 Experiment
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ischemic Cerebrovascular Solutions Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ischemic Cerebrovascular Solutions Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ischemic Cerebrovascular Solutions Market Size Forecast by Type
11.6.1 Medication
11.6.2 Surgical Treatment
11.6.3 Endovascular Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ischemic Cerebrovascular Solutions Market Size Forecast by Applications
11.10.1 Medical Treatment
11.10.2 Experiment
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ischemic Cerebrovascular Solutions Analysis and Forecast
12.1 Introduction
12.2 Latin America Ischemic Cerebrovascular Solutions Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ischemic Cerebrovascular Solutions Market Size Forecast by Type
12.6.1 Medication
12.6.2 Surgical Treatment
12.6.3 Endovascular Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ischemic Cerebrovascular Solutions Market Size Forecast by Applications
12.10.1 Medical Treatment
12.10.2 Experiment
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ischemic Cerebrovascular Solutions Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ischemic Cerebrovascular Solutions Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ischemic Cerebrovascular Solutions Market Size Forecast by Type
13.6.1 Medication
13.6.2 Surgical Treatment
13.6.3 Endovascular Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ischemic Cerebrovascular Solutions Market Size Forecast by Applications
13.10.1 Medical Treatment
13.10.2 Experiment
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ischemic Cerebrovascular Solutions Market: Competitive Dashboard
14.2 Global Ischemic Cerebrovascular Solutions Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 MicroPort
14.3.2 Stryker Corporation
14.3.3 Acandis GmbH
14.3.4 Medicut Stent Technology
14.3.5 Lepu Medical Technology
14.3.6 Medtronic
14.3.7 Robocath
14.3.8 Capture Vascular Inc
14.3.9 Auris Health Inc
14.3.10 Stereotaxis
